1 |
Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012[J]. Int J Cancer, 2015, 136(5): E359-E386.
|
2 |
Bachar G, Hod R, Goldstein DP, et al. Outcome of oral tongue squamous cell carcinoma in patients with and without known risk factors[J]. Oral Oncol, 2011, 47(1): 45-50.
|
3 |
钟来平. 口腔鳞状细胞癌临床诊治的规范化和个体化:机遇与挑战[J]. 华西口腔医学杂志, 2020, 38(5): 484-488.
|
|
Zhong LP. Standardized and individualized diagnosis and treatment of oral squamous cell carcinoma: opportunities and challenges[J]. West China J Stomatol, 2020, 38(5): 484-488.
|
4 |
Miranda-Filho A, Bray F. Global patterns and trends in cancers of the lip, tongue and mouth[J]. Oral Oncol, 2020, 102: 104551.
|
5 |
Kim YJ, Kim JH. Increasing incidence and improving survival of oral tongue squamous cell carcinoma[J]. Sci Rep, 2020, 10(1): 7877.
|
6 |
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015[J]. CA Cancer J Clin, 2015, 65(1): 5-29.
|
7 |
Siegel RL, Miller KD, Fuchs HE, et al. Cancer Statistics, 2021[J]. CA Cancer J Clin, 2021, 71(1): 7-33.
|
8 |
Guthrie GJ, Roxburgh CS, Farhan-Alanie OM, et al. Comparison of the prognostic value of longitudinal measurements of systemic inflammation in patients undergoing curative resection of colorectal cancer[J]. Br J Cancer, 2013, 109(1): 24-28.
|
9 |
Coussens LM, Werb Z. Inflammation and cancer[J]. Nature, 2002, 420(6917): 860-867.
|
10 |
Allin KH, Bojesen SE, Nordestgaard BG. Baseline C-reactive protein is associated with incident cancer and survival in patients with cancer[J]. J Clin Oncol, 2009, 27(13): 2217-2224.
|
11 |
Servais C, Erez N. From sentinel cells to inflammatory culprits: cancer-associated fibroblasts in tumour-related inflammation[J]. J Pathol, 2013, 229(2): 198-207.
|
12 |
Hanahan D, Weinberg RA. Hallmarks of cancer: the ne-xt generation[J]. Cell, 2011, 144(5): 646-674.
|
13 |
Swierczak A, Mouchemore KA, Hamilton JA, et al. Neutrophils: important contributors to tumor progression and metastasis[J]. Cancer Metastasis Rev, 2015, 34(4): 735-751.
|
14 |
Nieswandt B, Hafner M, Echtenacher B, et al. Lysis of tumor cells by natural killer cells in mice is impeded by platelets[J]. Cancer Res, 1999, 59(6): 1295-1300.
|
15 |
Stone RL, Nick AM, McNeish IA, et al. Paraneoplastic thrombocytosis in ovarian cancer[J]. N Engl J Med, 2012, 366(7): 610-618.
|
16 |
Mantovani A, Allavena P, Sica A, et al. Cancer-related inflammation[J]. Nature, 2008, 454(7203): 436-444.
|
17 |
Spitzer MH, Carmi Y, Reticker-Flynn NE, et al. Syste⁃mic immunity is required for effective cancer immunothe⁃rapy[J]. Cell, 2017, 168(3): 487-502.e15.
|
18 |
MacDonald N. Cancer cachexia and targeting chronic inflammation: a unified approach to cancer treatment and palliative/supportive care[J]. J Support Oncol, 2007, 5(4):157-162, 164-166, 183.
|
19 |
Guthrie GJ, Charles KA, Roxburgh CS, et al. The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer[J]. Crit Rev Oncol Hematol, 2013, 88(1): 218-230.
|
20 |
el-Hag A, Clark RA. Immunosuppression by activated human neutrophils. Dependence on the myeloperoxidase system[J]. J Immunol, 1987, 139(7): 2406-2413.
|
21 |
Dumitru CA, Lang S, Brandau S. Modulation of neutrophil granulocytes in the tumor microenvironment: mechanisms and consequences for tumor progression[J]. Semin Cancer Biol, 2013, 23(3): 141-148.
|
22 |
Ley K, Laudanna C, Cybulsky MI, et al. Getting to the site of inflammation: the leukocyte adhesion cascade updated[J]. Nat Rev Immunol, 2007, 7(9): 678-689.
|
23 |
Liang W, Ferrara N. The complex role of neutrophils in tumor angiogenesis and metastasis[J]. Cancer Immunol Res, 2016, 4(2): 83-91.
|
24 |
Schumacher D, Strilic B, Sivaraj KK, et al. Platelet-derived nucleotides promote tumor-cell transendothelial mi-gration and metastasis via P2Y2 receptor[J]. Cancer Cell, 2013, 24(1): 130-137.
|
25 |
Zhang N, Zhang WJ, Cai HQ, et al. Platelet adhesion and fusion to endothelial cell facilitate the metastasis of tumor cell in hypoxia-reoxygenation condition[J]. Clin Exp Metastasis, 2011, 28(1): 1-12.
|
26 |
Shao Y, Lo CM, Ling CC, et al. Regulatory B cells acce-lerate hepatocellular carcinoma progression via CD40/CD154 signaling pathway[J]. Cancer Lett, 2014, 355(2): 264-272.
|